Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Alvespimycin

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Alvespimycin 17-DMAG HSP90 Chaperone protein folding Phase 1, 2 Sigma-Aldrich D5193

Cell Line (34)
Cell LineAUCGI50
HepG20.360.025
JHH50.40.026
PLC.PRF50.440.033
HCC.1.10.470.081
HCC.1.20.480.05
Huh70.510.053
HLF0.550.083
Huh10.560.118
JHH70.560.092
HLE0.570.094
SNU4750.580.168
MHCC97H0.610.39
SNU8860.610.21
Hep3B0.610.29
Huh60.610.378


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it